Home LiteratureArticle Details
PMID: 7536096 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't

The role of nitric oxide in cardiac depression induced by interleukin-1 beta and tumour necrosis factor-alpha.

British journal of pharmacology ·Vol. 114 ·No. 1 ·1995-01-00 ·Pages 27-34

Schulz R, Panas DL, Catena R, Moncada S, Olley PM, Lopaschuk GD

Abstract

1. Myocardial dysfunction during septic shock is associated with enhanced production of cytokines such as interleukin-1 beta (IL-1 beta) and tumour necrosis factor-alpha (TNF-alpha). These cytokines depress cardiac mechanical function by a mechanism which is not well defined. 2. Bacterial endotoxin or cytokines cause the expression of Ca(2+)-independent nitric oxide (NO) synthase in cardiac myocytes, vascular endothelial cells and endocardial endothelial cells, causing enhanced production of NO. As NO has negative inotropic actions on cardiac muscle, we tested the sum effects of IL-1 beta plus TNF-alpha in the intact heart to determine whether enhanced expression of NO synthase activity in the cells that comprise the heart is involved in cardiac depression associated with cytokine stimulation. 3. Rat isolated working hearts perfused with IL-1 beta plus TNF-alpha showed a markedly greater depression in contractile function, measured as cardiac work, after 2 h of perfusion compared with time-matched control hearts. The depressant action of IL-1 beta plus TNF-alpha was first apparent after 1 h of perfusion; no early (15 min) cardiac depressant actions were seen. 4. The competitive inhibitor of Ca(2+)-dependent and Ca(2+)-independent NO synthases, NG-nitro-L-arginine methyl ester (L-NAME, 3 microM) when given concurrently with IL-1 beta plus TNF-alpha prevented the loss in contractile function such that these hearts after 2 h of perfusion had similar function to time-matched controls. L-NAME did not acutely reverse the loss of contractile function in hearts exposed for 2 h to IL-1 beta plus TNF-alpha. The protective action of L-NAME in the presence of cytokines was concentration-dependent and was not seen at a higher concentration (10 micro M) due to the significant reduction in coronary flow observed at this concentration.5. In contrast, when L-NAME (3 micro M) was given in the absence of IL-l beta plus TNF-alpha it depressed contractile function over the 2 h perfusion period by significantly reducing coronary flow.6. Inhibition of protein synthesis with cycloheximide (Cx) abolished the loss in function that occurred over 2h in both control and IL-1 beta plus TNF-a-treated hearts.7. Inducible, Ca2+-independent NO synthase activity was not observed in freshly isolated hearts but was observed in control hearts perfused for 2 h in vitro and was doubled in hearts perfused with IL-1 beta plus TNF-a. Cx prevented the expression of Ca2+-independent NO synthase in both control and cytokine-treated hearts.8. In summary, these results suggest that the depression of myocardial function by IL-l beta plus TNF-alpha is mediated, at least in part, by induction of Ca2+-independent NO synthase activity in the heart.

MeSH Terms
Amino Acid Oxidoreductases Animals Arginine/analogs & derivatives,pharmacology Coronary Circulation/drug effects Interleukin-1/pharmacology Male Myocardial Contraction/drug effects Myocardium/pathology NG-Nitroarginine Methyl Ester Nitric Oxide/antagonists & inhibitors,pharmacology Nitric Oxide Synthase Rats Rats, Sprague-Dawley Tumor Necrosis Factor-alpha/pharmacology
Chemicals
Interleukin-1 Tumor Necrosis Factor-alpha Nitric Oxide Arginine Nitric Oxide Synthase Amino Acid Oxidoreductases NG-Nitroarginine Methyl Ester
Authors & Affiliations
6 authors, click to expand affiliations / ORCID
Schulz R
Department of Pediatrics, University of Alberta, Edmonton, Canada.
Panas D L
Catena R
Moncada S
Olley P M
Lopaschuk G D
References (47)
47 references, click to expand
  1. Characterization of three inhibitors of endothelial nitric oxide synthase in vitro and in vivo.
    Br J Pharmacol. 1990 Nov;101(3):746-52 PMID: 1706208
  2. Role of NO in vascular smooth muscle and cardiac muscle function.
    Trends Pharmacol Sci. 1994 Jul;15(7):255-9 PMID: 7940989
  3. The proinflammatory cytokines interleukin-1 and tumor necrosis factor and treatment of the septic shock syndrome.
    J Infect Dis. 1991 Jun;163(6):1177-84 PMID: 2037782
  4. Nitric oxide: physiology, pathophysiology, and pharmacology.
    Pharmacol Rev. 1991 Jun;43(2):109-42 PMID: 1852778
  5. Factors released from endocardium of the ferret and pig modulate myocardial contraction.
    J Physiol. 1991 Aug;439:1-14 PMID: 1716674
  6. Expression of tumor necrosis factor in human acute cardiac rejection. An immunohistochemical and immunoblotting study.
    Am J Pathol. 1991 Oct;139(4):709-15 PMID: 1928295
  7. Inhibition of nitric oxide synthesis in septic shock: how much is beneficial?
    Lancet. 1991 Dec 21-28;338(8782-8783):1555-7 PMID: 1683974
  8. Effect of nitric oxide synthase inhibitors on hypotension in patients with septic shock.
    Lancet. 1991 Dec 21-28;338(8782-8783):1557-8 PMID: 1720856
  9. Nitric oxide synthase in cultured endocardial cells of the pig.
    Br J Pharmacol. 1991 Sep;104(1):21-4 PMID: 1723915
  10. Evidence for cytokine-inducible nitric oxide synthesis from L-arginine in patients receiving interleukin-2 therapy.
    J Clin Invest. 1992 Mar;89(3):867-77 PMID: 1541678
  11. Lysoplasmenylethanolamine accumulation in ischemic/reperfused isolated fatty acid-perfused hearts.
    Circ Res. 1992 Jun;70(6):1161-8 PMID: 1576737
  12. EPR detection of heme and nonheme iron-containing protein nitrosylation by nitric oxide during rejection of rat heart allograft.
    J Biol Chem. 1992 Jun 5;267(16):10994-8 PMID: 1375934
  13. Induction and potential biological relevance of a Ca(2+)-independent nitric oxide synthase in the myocardium.
    Br J Pharmacol. 1992 Mar;105(3):575-80 PMID: 1378338
  14. Negative inotropic effects of cytokines on the heart mediated by nitric oxide.
    Science. 1992 Jul 17;257(5068):387-9 PMID: 1631560
  15. Protective and pathological roles of nitric oxide in endotoxin shock.
    Cardiovasc Res. 1992 Jan;26(1):48-57 PMID: 1516112
  16. Interferon-gamma and tumor necrosis factor synergize to induce nitric oxide production and inhibit mitochondrial respiration in vascular smooth muscle cells.
    Circ Res. 1992 Nov;71(5):1268-76 PMID: 1394884
  17. Role of nitric oxide synthesis in the regulation of coronary vascular tone in the isolated perfused rabbit heart.
    Cardiovasc Res. 1992 May;26(5):508-12 PMID: 1446321
  18. Nitric oxide synthase activities in human myocardium.
    Lancet. 1993 Jan 9;341(8837):84-5 PMID: 7678120
  19. NG-nitro L-arginine methyl ester and other alkyl esters of arginine are muscarinic receptor antagonists.
    Circ Res. 1993 Feb;72(2):387-95 PMID: 7678206
  20. Effects of E. coli endotoxemia on ventricular performance.
    Am J Physiol. 1966 Aug;211(2):307-13 PMID: 4288377
  21. Effect of pressure development on oxygen consumption by isolated rat heart.
    Am J Physiol. 1967 Apr;212(4):804-14 PMID: 6024443
  22. Circulatory effects of hydrocortisone and protection against endotoxin shock in cats.
    Eur J Pharmacol. 1970 Mar;9(3):311-8 PMID: 4909371
  23. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding.
    Anal Biochem. 1976 May 7;72:248-54 PMID: 942051
  24. Utilization of energy-providing substrates in the isolated working rat heart.
    Biochem J. 1980 Mar 15;186(3):701-11 PMID: 6994712
  25. Development of myocardial dysfunction in endotoxin shock.
    Am J Physiol. 1985 Jun;248(6 Pt 2):H818-26 PMID: 4003562
  26. Differentiation of murine macrophages to express nonspecific cytotoxicity for tumor cells results in L-arginine-dependent inhibition of mitochondrial iron-sulfur enzymes in the macrophage effector cells.
    J Immunol. 1988 Apr 15;140(8):2829-38 PMID: 2451695
  27. Interleukin-2 administration causes reversible hemodynamic changes and left ventricular dysfunction similar to those seen in septic shock.
    Chest. 1988 Oct;94(4):750-4 PMID: 3262487
  28. Myocardial toxic effects during recombinant interleukin-2 therapy.
    J Natl Cancer Inst. 1989 Jan 4;81(1):59-63 PMID: 2783257
  29. Myocardial dysfunction in sepsis.
    Crit Care Clin. 1989 Jan;5(1):99-118 PMID: 2647229
  30. Induction of endogenous cytokine-mRNA in circulating peripheral blood mononuclear cells by IL-2 administration to cancer patients.
    J Immunol. 1989 Jul 15;143(2):736-9 PMID: 2661690
  31. The cardiovascular response of normal humans to the administration of endotoxin.
    N Engl J Med. 1989 Aug 3;321(5):280-7 PMID: 2664516
  32. Reversible cardiac dysfunction associated with interferon alfa therapy in AIDS patients with Kaposi's sarcoma.
    N Engl J Med. 1989 Nov 2;321(18):1246-9 PMID: 2638573
  33. Myocardial function in sepsis and endotoxin shock.
    Am J Physiol. 1989 Dec;257(6 Pt 2):R1265-81 PMID: 2690645
  34. Interleukin-1-induced myocardial depression in an isolated beating heart preparation.
    J Heart Transplant. 1989 Nov-Dec;8(6):460-4 PMID: 2614547
  35. NG-methyl-L-arginine inhibits tumor necrosis factor-induced hypotension: implications for the involvement of nitric oxide.
    Proc Natl Acad Sci U S A. 1990 May;87(9):3629-32 PMID: 2333306
  36. Control of coronary vascular tone by nitric oxide.
    Circ Res. 1990 Jun;66(6):1561-75 PMID: 2160870
  37. Adoptive immunotherapy of human cancer: the cytokine cascade and monocyte activation following high-dose interleukin 2 bolus treatment.
    Cancer Res. 1990 Sep 15;50(18):5795-800 PMID: 2118421
  38. Effects of interleukin 2 on cardiac function in the isolated rat heart.
    J Clin Invest. 1990 Sep;86(3):845-50 PMID: 2394834
  39. Dexamethasone prevents the induction by endotoxin of a nitric oxide synthase and the associated effects on vascular tone: an insight into endotoxin shock.
    Biochem Biophys Res Commun. 1990 Dec 14;173(2):541-7 PMID: 1701990
  40. Induction of nitric oxide synthase by cytokines in vascular smooth muscle cells.
    FEBS Lett. 1990 Nov 26;275(1-2):87-90 PMID: 1702067
  41. Porcine ventricular endocardial cells in culture express the inducible form of nitric oxide synthase.
    Br J Pharmacol. 1993 Apr;108(4):1107-10 PMID: 7683563
  42. Abnormal contractile function due to induction of nitric oxide synthesis in rat cardiac myocytes follows exposure to activated macrophage-conditioned medium.
    J Clin Invest. 1993 May;91(5):2314-9 PMID: 8486792
  43. Tumor necrosis factor downregulates an endothelial nitric oxide synthase mRNA by shortening its half-life.
    Circ Res. 1993 Jul;73(1):205-9 PMID: 7685252
  44. Nitric oxide attenuates cardiac myocyte contraction.
    Am J Physiol. 1993 Jul;265(1 Pt 2):H176-82 PMID: 8342632
  45. Interleukin-1 beta modulates myocardial contraction via dexamethasone sensitive production of nitric oxide.
    Cardiovasc Res. 1993 Aug;27(8):1486-90 PMID: 8221802
  46. Tumor necrosis factor, other cytokines and disease.
    Annu Rev Cell Biol. 1993;9:317-43 PMID: 8280464
  47. Left ventricular contractility and diastolic properties in anesthetized dogs after severe burns.
    Am J Physiol. 1991 May;260(5 Pt 2):H1433-42 PMID: 2035665
Article Info
Journal
British journal of pharmacology
Abbr.
Br J Pharmacol
ISSN
0007-1188
Published
1995-01-00
Pages
27-34
Language
English
Region
England
NLM ID
7502536
PMCID
PMC1510184
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]